Chiron Capital Management LLC Sells 10,402 Shares of GE HealthCare Technologies Inc. $GEHC

Chiron Capital Management LLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 44.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,906 shares of the company’s stock after selling 10,402 shares during the quarter. Chiron Capital Management LLC’s holdings in GE HealthCare Technologies were worth $844,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of GEHC. Auto Owners Insurance Co increased its stake in shares of GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after acquiring an additional 33,629,559 shares during the period. State Street Corp boosted its holdings in GE HealthCare Technologies by 1.6% in the second quarter. State Street Corp now owns 20,861,566 shares of the company’s stock valued at $1,335,349,000 after purchasing an additional 323,090 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in GE HealthCare Technologies by 13.2% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock valued at $861,307,000 after purchasing an additional 1,571,226 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in GE HealthCare Technologies by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock valued at $384,219,000 after purchasing an additional 105,995 shares during the last quarter. Finally, Van ECK Associates Corp boosted its holdings in GE HealthCare Technologies by 4.1% in the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock valued at $286,933,000 after purchasing an additional 177,028 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GEHC traded up $2.04 on Thursday, reaching $70.51. The stock had a trading volume of 1,349,499 shares, compared to its average volume of 4,252,275. The business’s 50-day moving average price is $68.58 and its two-hundred day moving average price is $66.76. The company has a market cap of $31.85 billion, a P/E ratio of 16.17, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The business had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period in the prior year, the company posted $1.06 EPS. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s payout ratio is currently 3.21%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Needham & Company LLC reiterated a “buy” rating and set a $93.00 price objective on shares of GE HealthCare Technologies in a research note on Monday, October 5th. Citigroup lowered their target price on GE HealthCare Technologies from $75.00 to $71.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. UBS Group raised their target price on GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. BMO Capital Markets started coverage on GE HealthCare Technologies in a research report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 price target for the company. Finally, Zacks Research raised GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $78.35.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology and healthcare services company that develops, manufactures and supports products used by hospitals, clinicians and researchers. Its offerings are designed to assist with disease detection, diagnosis, treatment, patient monitoring and clinical workflow management.

The company’s portfolio includes computed tomography, magnetic resonance imaging, X-ray and molecular imaging systems; ultrasound equipment; patient monitoring and anesthesia delivery technologies; and pharmaceutical diagnostics, including contrast agents used in medical imaging.